Trial intelligence / Profile preview

Movicol vs Lactulose for Faecal Impaction and Maintenance in Children

NCT00403858Phase 2Completed

Sponsor
Norgine
Start
Oct 2000
Modality
Polymer-based Nanoparticles
Countries
1
01

Overview

A Phase 2 trial of polyethylene glycol in fecal impaction, sponsored by Norgine. Started Oct 2000; status: completed.

02

Drugs

polyethylene glycol
03

Conditions

fecal impaction

Beyond the preview

Go deeper on NCT00403858.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00403858.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call